Loading
₹4,716.20
−55.80−1.17%today
Market closed · 7 Oct, 3:30 pm
+33.34%over 1 year
Today's range
₹4,679.00₹4,791.30
52-week range
₹3,480.60₹5,250.00
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 13,753 | 2,163 | 15.7% | 63.92 |
| FY25 | 11,317 | 1,911 | 16.9% | 56.47 |
| FY24 | 10,562 | 1,656 | 15.7% | 48.94 |
| FY23 | 9,464 | 1,245 | 13.2% | 36.79 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 68.31% | 68.31% | 68.31% | 68.31% |
| FIIs | 15.44% | 16.18% | 16.13% | 15.92% |
| DIIs | 9.83% | 9.06% | 9.14% | 9.28% |
| of which mutual funds | 4.94% | 4.45% | 4.83% | 5.12% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 6.42% | 6.45% | 6.42% | 6.49% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Divi's Laboratories Ltd.DIVISLAB | 9,588.00 | +0.40% | 2,54,531 |
| Torrent Pharmaceuticals Ltd.TORNTPHARM · this stock | 4,716.20 | −1.17% | 1,79,385 |
| Zydus Lifesciences Ltd.ZYDUSLIFE | 1,153.00 | −0.56% | 1,15,012 |
| Apollo Hospitals Enterprise Ltd.APOLLOHOSP | 7,917.00 | +0.03% | 1,13,834 |
| Laurus Labs Ltd.LAURUSLABS | 2,052.80 | +0.14% | 1,10,915 |
| Cipla Ltd.CIPLA | 1,327.20 | −0.97% | 1,07,221 |
| Mankind Pharma Ltd.MANKIND | 2,500.00 | 0.00% | 1,03,261 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.